The company’s board approved base salary increases of about 3% for various executives for fiscal year 2024. Here are the updated base salaries:
- Tim Hingtgen, CEO: $1,326,125
- Kevin Hammons, CFO: $795,675
- Lynn Simon, MD, president of healthcare innovation and chief medical officer: $679,691
- Mark Medley, regional president-region operations: $672,000
- Kevin Stockton, executive vice president of operations and development: $710,000
- Chad Campbell, regional president-region operations $672,000
CHS also approved performance goals as part of its employee performance incentive plan. The following target opportunities are expressed as a percentage of base salary:
- Mr. Hingtgen: 225%
- Mr. Hammons: 125%
- Dr. Simon: 105%
- Mr. Medley: 115%
- Mr. Stockton: 105%
- Mr. Campbell: 115%
The executives will also have the opportunity to earn an additional percentage of their base salary if they hit specific non-financial performance targets up to a maximum of an additional 40% for Mr. Hingtgen; 35% for Mr. Hammons; 20% for each of Dr. Simon and Mr. Stockton; and 10% for each of Mr. Medley and Mr. Campbell.
Each leader can earn a further percentage of their base pay for overachievement of performance goals up to a maximum of an additional 35% for Mr. Hingtgen and an additional 25% for each of Mr. Hammons, Dr. Simon, Mr. Stockton, Mr. Medley and Mr. Campbell.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.